Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitoring, MCOT, ECG, ICP, ILRs, Blood Glucose Monitoring, Blood Pressure Monitor), End-User (Hospitals, ASCs) - Global Forecast to 2025

患者モニタリング装置の世界市場予測(~2025):製品別、エンドユーザー別

◆タイトル:Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitoring, MCOT, ECG, ICP, ILRs, Blood Glucose Monitoring, Blood Pressure Monitor), End-User (Hospitals, ASCs) - Global Forecast to 2025
◆商品コード:MD 2436
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年11月13日
◆ページ数:341
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は患者モニタリング装置の世界市場が2020年364億ドルから2025年551億ドルまで、年平均8.6%成長すると予想しています。本調査レポートでは、患者モニタリング装置の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(血糖、心臓、マルチパラメーター、呼吸、温度)分析、エンドユーザー別(病院、外来手術センター、在宅医療、その他)分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・患者モニタリング装置の世界市場規模:製品別(血糖、心臓、マルチパラメーター、呼吸、温度)
・患者モニタリング装置の世界市場規模:エンドユーザー別(病院、外来手術センター、在宅医療、その他)
・患者モニタリング装置の世界市場規模:地域別
・競争状況
・企業情報

“The patient monitoring devices market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6% during the forecast period.”
Growth of the market is mainly attributed to the technological advancements; increasing incidences of infectious diseases, and growing public and private investments, funding, and grants are driving the globalpatient monitoring devices market.However, complex regulatory frameworks that delay the approval of new patient monitoring devices is expected to challenge market growth to a certain extent.

“In terms of products, blood glucose monitoring systems segment to register significant growth during the forecast period.”
Based on the product, the patient monitoring devices market is segmented into blood glucose monitoring systems, cardiac monitoring devices, multiparameter monitoring devices, respiratory monitoring devices, temperature monitoring devices, hemodynamic/pressure monitoring devices, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices and other patient monitoring devices. Significant growth of the segment is attributed to the ongoing product approval of continuous glucose monitoring systems, advantages offered by continuous glucose monitoring systemsover self-monitoring blood glucose systems, and technological advancements in the market. Continuous glucose monitoring systemsoffer a wide range of advantages over self-monitoring blood glucose systems, such as reduced cost, shortened detection time, and non-invasive detection. These advantages offered by the continuous glucose monitoring systems have led to the growth of this segment.

“Hospitals segment is expected to account for the largest share of the patient monitoring devices market, by the end user.”
On the basis of end-users, the patient monitoring devices market has been segmented into hospitals, ambulatory surgery centers, home care settings and other end users. The growth of this segment is attributed to the significant number of availability of state-of-the-art facilities for diagnosis, treatment, and disease management, as well as trained personnel, has ensured a steady demand for hospital-based care and the growing number of hospitals across major markets. The inflow of patients is considerably higher in hospitals as compared to other healthcare settings, which is another key driver for market growth. More screening and diagnostic procedures are conducted in hospitals than in other medical facilities, contributing to the large share of this end-user segment.

“Asia Pacific marketis expected to grow at the highest CAGR during the forecast period.”
The Asia Pacific market isestimated to grow at the highestCAGR during the forecast period majorly due to the heavy burden of infectious diseases, rising healthcare expenditure, and increasing geriatric population. Apart from this, the rising number of hospitals and ambulatory surgical centers in the APAC region is expected to propel the market for patient monitoring devices.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type:Tier 1–45%, Tier 2–34%, and Tier 3– 21%
• By Designation: C-level–47%, Director-level–33%, and Others–20%
• By Region:North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%

Some of the prominent players in the patient monitoring devices market include Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Drägerwerk AG & Co. KGaA (Germany), Edwards Lifesciences Corporation (US), OMRON Corporation (Japan), Masimo Corporation (US), Compumedics Limited (Australia), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nihon Kohden Corporation (Japan), Natus Medical (US), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Getinge AB (Sweden), Boston Scientific Corporation (US), Dexcom, Inc. (US), Nonin (US), BIOTRONIK (Germany), SCHILLER (Switzerland), and BioTelemetry, Inc. (US), among others.

Research Coverage:
This report studies the patient monitoring devicesmarket based onproduct, enduser, and region. It also coversthe factors affecting market growth,analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report:
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Market Penetration:Comprehensive information on the product portfolios offered by the top players in the patient monitoring devicesmarket.
 Product Development/Innovation:Detailed insights on the upcoming trends, R&D activities, and product launches in the patient monitoring devicesmarket.
 Market Development:Comprehensive information on lucrative emerging regions.
 Market Diversification:Exhaustive information about new products, growing geographies, and recent developments in the patient monitoring devicesmarket.
 Competitive Assessment:In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

【レポートの目次】

1 INTRODUCTION 45
1.1 OBJECTIVES OF THE STUDY 45
1.2 MARKET DEFINITION 45
TABLE 1 INCLUSIONS & EXCLUSIONS 45
1.3 MARKET SCOPE 46
1.3.1 MARKETS COVERED 46
1.3.2 YEARS CONSIDERED FOR THE STUDY 47
1.4 CURRENCY 47
1.5 LIMITATIONS 47
1.6 STAKEHOLDERS 47
1.7 SUMMARY OF CHANGES 48
2 RESEARCH METHODOLOGY 51
2.1 RESEARCH DATA 51
FIGURE 1 RESEARCH DESIGN 51
2.1.1 SECONDARY DATA 52
2.1.1.1 Key data from secondary sources 52
2.1.2 PRIMARY DATA 53
2.1.2.1 Breakdown of primaries 54
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 54
2.2 MARKET ESTIMATION METHODOLOGY 54
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 55
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION 55
FIGURE 4 MARKET SIZE ESTIMATION: VENDOR REVENUE-BASED MARKET ESTIMATION 56
2.2.2 END USER-BASED MARKET ESTIMATION 57
FIGURE 5 MARKET SIZE ESTIMATION: END USER-BASED MARKET ESTIMATION 57
2.2.3 PRIMARY RESEARCH VALIDATION 57
2.3 DATA TRIANGULATION METHODOLOGY 58
2.3.1 MARKET BREAKDOWN AND DATA TRIANGULATION 58
FIGURE 6 DATA TRIANGULATION METHODOLOGY 58
2.4 RESEARCH ASSUMPTIONS 59
2.5 RESEARCH LIMITATIONS 59
3 EXECUTIVE SUMMARY 60
FIGURE 7 PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION) 60
FIGURE 8 PATIENT MONITORING DEVICES MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 61
FIGURE 9 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING
THE FORECAST PERIOD 62
4 PREMIUM INSIGHTS 63
4.1 PATIENT MONITORING DEVICES MARKET OVERVIEW 63
FIGURE 10 NEW PRODUCT APPROVALS AND LAUNCHES–A KEY FACTOR DRIVING
THE GROWTH OF THE PATIENT MONITORING DEVICES MARKET ACROSS
THE GLOBE 63
4.2 PATIENT MONITORING DEVICES MARKET, BY PRODUCT 64
FIGURE 11 BLOOD GLUCOSE MONITORING DEVICES TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD 64
4.3 GEOGRAPHIC ANALYSIS: PATIENT MONITORING DEVICES MARKET,
BY COUNTRY/REGION 65
FIGURE 12 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING
THE FORECAST PERIOD 65
4.4 PATIENT MONITORING DEVICES MARKET SHARE, BY END USER 66
FIGURE 13 HOSPITALS TO ACCOUNT FOR THE LARGEST MARKET SHARE DURING
THE FORECAST PERIOD 66
4.5 GEOGRAPHICAL SNAPSHOT OF THE PATIENT MONITORING DEVICES MARKET 67
FIGURE 14 MARKET IN CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
FIGURE 15 PATIENT MONITORING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68
5.2.1 DRIVERS 69
5.2.1.1 Technological advancements in patient monitoring devices 69
5.2.1.1.1 User-centric design for wearable devices 69
5.2.1.1.2 Non-invasive hemodynamic monitoring 70
5.2.1.1.3 Digital sensors 70
5.2.1.1.4 Mobile-grade EEG devices 71
5.2.1.2 Rising prevalence of chronic diseases 71
5.2.1.3 Availability of wireless monitoring devices 73
TABLE 2 RECENT PRODUCT INNOVATIONS IN THE PATIENT MONITORING DEVICES MARKET 74
5.2.1.4 Growing preference for wearable patient monitoring devices, biosensors, and smart implants among healthcare payers 74
5.2.1.5 Growing investments, funds, and grants 75
5.2.2 RESTRAINTS 76
5.2.2.1 Risks associated with invasive monitoring devices 76
5.2.2.2 High cost of patient monitoring products and inadequate reimbursement 77
5.2.3 OPPORTUNITIES 77
5.2.3.1 Increasing demand for non-invasive and minimally invasive devices 77
5.2.3.2 Growing demand for patient monitoring devices in non-hospital settings 78
5.2.4 CHALLENGES 78
5.2.4.1 Lack of skilled healthcare professionals 78
5.2.4.2 Increasing pricing pressure on market players 79
5.3 VALUE CHAIN ANALYSIS 80
FIGURE 16 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING THE MANUFACTURING PHASE 80
FIGURE 17 ECOSYSTEM 81
5.4 REGULATORY ANALYSIS 81
5.4.1 NORTH AMERICA 81
5.4.1.1 US 81
TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION 82
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 82
5.4.1.2 Canada 83
TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 83
FIGURE 18 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 84
5.4.2 EUROPE 84
FIGURE 19 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 85
5.4.3 ASIA PACIFIC 86
5.4.3.1 Japan 86
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 86
5.4.3.2 China 87
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES 87
5.4.3.3 India 88
5.5 COVID-19 IMPACT ON THE PATIENT MONITORING DEVICES MARKET 89
6 PATIENT MONITORING DEVICES MARKET, BY PRODUCT 91
6.1 INTRODUCTION 92
TABLE 8 PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 92
6.2 BLOOD GLUCOSE MONITORING SYSTEMS MARKET 93
6.2.1 INTRODUCTION 94
TABLE 9 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 94
TABLE 10 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 94
TABLE 11 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY END USER,
2018–2025 (USD MILLION) 95
6.2.2 SELF-MONITORING BLOOD GLUCOSE SYSTEMS 95
6.2.2.1 Rising adoption of integrated glucose monitoring systems to drive growth in this market 95
TABLE 12 SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 96

6.2.3 CONTINUOUS GLUCOSE MONITORING SYSTEMS 97
6.2.3.1 Growing product launches & approvals and evolving reimbursement scenario for continuous glucose monitoring systems will drive market growth 97
TABLE 13 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION) 98
6.3 CARDIAC MONITORING DEVICES MARKET 99
6.3.1 INTRODUCTION 100
TABLE 14 CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 100
TABLE 15 CARDIAC MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 100
TABLE 16 CARDIAC MONITORING DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 101
6.3.2 ECG DEVICES 101
6.3.2.1 Low cost and wide applications of ECG devices to drive market growth 101
TABLE 17 ECG DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 102
6.3.3 IMPLANTABLE LOOP RECORDERS 102
6.3.3.1 High cost and limited applications limit the growth of this market segment to a certain extent 102
TABLE 18 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION,
2018–2025 (USD MILLION) 103
6.3.4 EVENT MONITORS 103
6.3.4.1 Emergence of portable and wireless event monitors to drive market growth 103
TABLE 19 EVENT MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION) 104
6.3.5 MOBILE CARDIAC TELEMETRY MONITORS 105
6.3.5.1 Availability of alternate technologies likely to hinder market growth 105
TABLE 20 MCT MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION) 105
6.3.6 SMART/WEARABLE ECG MONITORS 106
6.3.6.1 Need to minimize the treatment cost for CVD patients is likely to increase the adoption of smart/wearable ECG monitors 106
TABLE 21 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS 106
TABLE 22 SMART/WEARABLE ECG MONITORS MARKET, BY REGION,
2018–2025 (USD MILLION) 107
6.4 MULTI-PARAMETER MONITORING DEVICES MARKET 108
6.4.1 INTRODUCTION 109
TABLE 23 MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY,
2018–2025 (USD MILLION) 109
TABLE 24 MULTI-PARAMETER MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 109
TABLE 25 MULTI-PARAMETER MONITORING DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 110
6.4.2 LOW-ACUITY MONITORING DEVICES 110
6.4.2.1 Increasing adoption of low-acuity monitoring devices to improve care in general ward 110
TABLE 26 LOW-ACUITY MULTI-PARAMETER MONITORING DEVICES MARKET,
BY REGION, 2018–2025 (USD MILLION) 111
6.4.3 MID-ACUITY MONITORING DEVICES 111
6.4.3.1 Rising geriatric population is likely to increase market growth 111
TABLE 27 MID-ACUITY MULTI-PARAMETER MONITORING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 111
6.4.4 HIGH-ACUITY MONITORING DEVICES 112
6.4.4.1 Increasing partnerships between manufacturers and multinational hospitals are driving the sales of high-acuity monitoring devices 112
TABLE 28 HIGH-ACUITY MULTI-PARAMETER MONITORING DEVICES MARKET,
BY REGION, 2018–2025 (USD MILLION) 112
6.5 RESPIRATORY MONITORING DEVICES MARKET 113
6.5.1 INTRODUCTION 114
TABLE 29 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 114
TABLE 30 RESPIRATORY MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 114
TABLE 31 RESPIRATORY MONITORING DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 115
6.5.2 PULSE OXIMETERS 115
6.5.2.1 Rising adoption of pulse oximeters in home care settings is expected to drive market growth 115
TABLE 32 PULSE OXIMETERS MARKET, BY REGION, 2018–2025 (USD MILLION) 116
6.5.3 SPIROMETERS 116
6.5.3.1 Technological advancements to increase the adoption of spirometers 116
TABLE 33 SPIROMETERS MARKET, BY REGION, 2018–2025 (USD MILLION) 117
6.5.4 CAPNOGRAPHS 117
6.5.4.1 Extensive research in capnography has led to the development of improved capnographs, resulting in their increased commercial acceptance 117
TABLE 34 CAPNOGRAPHS MARKET, BY REGION, 2018–2025 (USD MILLION) 118
6.5.5 PEAK FLOW METERS 119
6.5.5.1 Peak flow meters are not preferred due to the high variability in measurements obtained from devices made by different manufacturers 119
TABLE 35 PEAK FLOW METERS MARKET, BY REGION, 2018–2025 (USD MILLION) 119
6.6 TEMPERATURE MONITORING DEVICES MARKET 120
6.6.1 INTRODUCTION 121
TABLE 36 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 121
TABLE 37 TEMPERATURE MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 121
TABLE 38 TEMPERATURE MONITORING DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 122
6.6.2 HANDHELD TEMPERATURE MONITORING DEVICES 122
6.6.2.1 Advantages associated with handheld temperature monitoring devices to drive market growth 122
TABLE 39 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS 123
TABLE 40 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 124
6.6.3 TABLE-TOP TEMPERATURE MONITORING DEVICES 124
6.6.3.1 Increasing risks associated with hypothermia during surgeries to drive the demand for table-top devices 124
TABLE 41 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 125
6.6.4 WEARABLE CONTINUOUS MONITORING DEVICES 125
6.6.4.1 Versatile functionalities offered by wearable continuous monitoring devices to drive their demand 125
TABLE 42 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS 126
TABLE 43 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 126
6.6.5 INVASIVE TEMPERATURE MONITORING DEVICES 127
6.6.5.1 Increasing prevalence of bloodstream infections with the use of invasive temperature monitoring devices is hindering market growth 127
TABLE 44 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 127
6.6.6 SMART TEMPERATURE MONITORING PATCHES 128
6.6.6.1 Long-term monitoring offered by smart temperature monitoring devices is a key factor driving market growth 128
TABLE 45 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS 129
TABLE 46 SMART TEMPERATURE MONITORING PATCHES MARKET, BY REGION,
2018–2025 (USD MILLION) 129
6.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET 130
6.7.1 INTRODUCTION 131
TABLE 47 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 48 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 131
TABLE 49 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY END USER, 2018–2025 (USD MILLION) 132
TABLE 50 HEMODYNAMIC/PRESSURE MONITORING SYSTEMS: ADVANTAGES & DISADVANTAGES 132
6.7.2 HEMODYNAMIC MONITORS 133
6.7.2.1 Influx of VC funding to drive market growth 133
TABLE 51 INDICATIVE LIST OF COMPANIES THAT RECEIVED VENTURE CAPITALIST FUNDING FOR THE HEMODYNAMIC MONITORING SYSTEMS 133
TABLE 52 HEMODYNAMIC MONITORS MARKET, BY REGION,
2018–2025 (USD MILLION) 134
6.7.3 BLOOD PRESSURE MONITORS 134
6.7.3.1 Development of wearable blood pressure monitors to drive the growth of this market segment 134
TABLE 53 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS 134
TABLE 54 BLOOD PRESSURE MONITORS MARKET, BY REGION,
2018–2025 (USD MILLION) 135
6.7.4 DISPOSABLES 136
6.7.4.1 Growing number of surgical procedures to drive the growth of this market segment 136
TABLE 55 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET,
BY REGION, 2018–2025 (USD MILLION) 136
6.8 FETAL AND NEONATAL MONITORING DEVICES 137
6.8.1 INTRODUCTION 138
TABLE 56 FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 138
TABLE 57 FETAL AND NEONATAL MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 138
TABLE 58 FETAL AND NEONATAL MONITORING DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 139
6.8.2 FETAL MONITORING DEVICES 139
6.8.2.1 Increasing number of obstetric complications and rising number of preterm and low-weight births are driving market growth 139
TABLE 59 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS 141
TABLE 60 FETAL MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 142
6.8.3 NEONATAL MONITORING DEVICES 142
6.8.3.1 Rising number of neonatal care facilities worldwide to drive growth in this market segment 142
TABLE 61 NEONATAL MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 144
6.9 NEUROMONITORING DEVICES MARKET 145
6.9.1 INTRODUCTION 146
TABLE 62 NEUROMONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 146
TABLE 63 NEUROMONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 146
TABLE 64 NEUROMONITORING DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 147
6.9.2 ELECTROENCEPHALOGRAPH MACHINES 147
6.9.2.1 Growing applications of EEG and technological advancements are the key drivers for this market segment 147
TABLE 65 ELECTROENCEPHALOGRAPH MACHINES MARKET, BY REGION,
2018–2025 (USD MILLION) 149
6.9.3 ELECTROMYOGRAPH MACHINES 149
6.9.3.1 Growing availability of reimbursements for EMG-assisted surgical procedures to drive market growth 149
TABLE 66 ELECTROMYOGRAPH MACHINES MARKET, BY REGION,
2018–2025 (USD MILLION) 150
6.9.4 CEREBRAL OXIMETERS 150
6.9.4.1 Growing cases of hypoxia during surgical procedures are likely to drive market growth 150
TABLE 67 CEREBRAL OXIMETERS MARKET, BY REGION, 2018–2025 (USD MILLION) 151
6.9.5 INTRACRANIAL PRESSURE MONITORS 151
6.9.5.1 Fatal consequences of high ICP make monitoring important—a key factor driving market growth 151
TABLE 68 INTRACRANIAL PRESSURE MONITORS MARKET, BY REGION,
2018–2025 (USD MILLION) 152
6.9.6 MAGNETOENCEPHALOGRAPH MACHINES 152
6.9.6.1 High implementation and maintenance costs of MEG devices are likely to hinder market growth 152
TABLE 69 MAGNETOENCEPHALOGRAPH MACHINES MARKET, BY REGION,
2018–2025 (USD MILLION) 153
6.9.7 TRANSCRANIAL DOPPLER MACHINES 153
6.9.7.1 Rising prevalence of strokes and cerebrovascular disorders will contribute to market growth 153
TABLE 70 TRANSCRANIAL DOPPLER MACHINES MARKET, BY REGION,
2018–2025 (USD MILLION) 154
6.10 WEIGHT MONITORING DEVICES MARKET 155
6.10.1 INTRODUCTION 156
TABLE 71 WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 156
TABLE 72 WEIGHT MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 156
TABLE 73 WEIGHT MONITORING DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 157
6.10.2 DIGITAL 157
6.10.2.1 Consumer preference for digital scales will contribute to market growth 157
TABLE 74 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 157
6.10.3 ANALOG 158
6.10.3.1 Rising prevalence of obesity and low cost of analog scales will contribute to market growth 158
TABLE 75 ANALOG WEIGHT MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 158
6.11 OTHER PATIENT MONITORING DEVICES MARKET 159
6.11.1 INTRODUCTION 159
TABLE 76 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS 159
TABLE 77 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS 160
TABLE 78 OTHER PATIENT MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 161
TABLE 79 OTHER PATIENT MONITORING DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 161
7 PATIENT MONITORING DEVICES MARKET, BY END USER 162
7.1 INTRODUCTION 163
TABLE 80 PATIENT MONITORING DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 163
7.2 HOSPITALS 163
7.2.1 HOSPITALS TO DOMINATE THE END-USER MARKET 163
TABLE 81 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS, BY REGION, 2018–2025 (USD MILLION) 164
7.3 AMBULATORY SURGERY CENTERS 164
7.3.1 PATIENTS ARE INCREASINGLY OPTING FOR AMBULATORY SURGERY CENTERS AS A MORE CONVENIENT ALTERNATIVE TO HOSPITAL-BASED OUTPATIENT PROCEDURES 164
TABLE 82 PATIENT MONITORING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2018–2025 (USD MILLION) 165
7.4 HOME CARE SETTINGS 165
7.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH 165
TABLE 83 PATIENT MONITORING DEVICES MARKET FOR HOME CARE SETTINGS,
BY REGION, 2018–2025 (USD MILLION) 166
7.5 OTHER END USERS 166
TABLE 84 PATIENT MONITORING DEVICES MARKET FOR OTHER END USERS,
BY REGION, 2018–2025 (USD MILLION) 167
8 PATIENT MONITORING DEVICES MARKET, BY REGION 168
8.1 INTRODUCTION 169
TABLE 85 PATIENT MONITORING DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 169
8.2 NORTH AMERICA 170
FIGURE 20 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SNAPSHOT 170
TABLE 86 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 171
TABLE 87 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 171
TABLE 88 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 172
TABLE 89 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 172
TABLE 90 NORTH AMERICA: MULTI-PARAMETER MONITORING DEVICES MARKET,
BY ACUITY, 2018–2025 (USD MILLION) 172
TABLE 91 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 173
TABLE 92 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 173
TABLE 93 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 173
TABLE 94 NORTH AMERICA: FETAL AND NEONATAL MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 174
TABLE 95 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 174
TABLE 96 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 174
TABLE 97 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2018–2025 (USD MILLION) 175
8.2.1 US 175
8.2.1.1 Growing number of FDA approvals for patient monitoring devices to support market growth in the US 175
TABLE 98 VC FUNDING IN THE PATIENT MONITORING DEVICES MARKET IN THE US 176
TABLE 99 US: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 177
TABLE 100 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 177
TABLE 101 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 178
TABLE 102 US: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY,
2018–2025 (USD MILLION) 178
TABLE 103 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 178
TABLE 104 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 179
TABLE 105 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 179
TABLE 106 US: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 179
TABLE 107 US: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 180
TABLE 108 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 180
8.2.2 CANADA 180
8.2.2.1 Growing public-private funding for research to drive market growth 180
TABLE 109 RESEARCH GRANTS IN THE PATIENT MONITORING DEVICES MARKET IN CANADA 181
TABLE 110 RECENT DEVELOPMENTS IN THE CANADIAN PATIENT MONITORING DEVICES MARKET 182
TABLE 111 CANADA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 183
TABLE 112 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 183
TABLE 113 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 184
TABLE 114 CANADA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 184
TABLE 115 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 184
TABLE 116 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 185
TABLE 117 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 185
TABLE 118 CANADA: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 185
TABLE 119 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 186
TABLE 120 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 186
8.3 EUROPE 187
TABLE 121 PRODUCT APPROVALS IN THE EUROPEAN PATIENT MONITORING DEVICES MARKET 187
TABLE 122 EUROPE: PATIENT MONITORING DEVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 188
TABLE 123 EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 188
TABLE 124 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 189
TABLE 125 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 189
TABLE 126 EUROPE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 189
TABLE 127 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 190
TABLE 128 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 190
TABLE 129 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 190
TABLE 130 EUROPE: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 191
TABLE 131 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 191
TABLE 132 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 191
TABLE 133 EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 192
8.3.1 GERMANY 192
8.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth in Germany 192
TABLE 134 RECENT DEVELOPMENTS IN THE GERMAN PATIENT MONITORING DEVICES MARKET 193
TABLE 135 GERMANY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 194
TABLE 136 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 194
TABLE 137 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 195
TABLE 138 GERMANY: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 195
TABLE 139 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 195
TABLE 140 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 196
TABLE 141 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 196
TABLE 142 GERMANY: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 196
TABLE 143 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 197
TABLE 144 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 197
8.3.2 UK 197
8.3.2.1 Increasing investments from public and private sectors play an important role in the growth of the patient monitoring devices market in the UK 197
TABLE 145 UK: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 198
TABLE 146 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 199
TABLE 147 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 199
TABLE 148 UK: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY,
2018–2025 (USD MILLION) 199
TABLE 149 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 200
TABLE 150 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 200
TABLE 151 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 200
TABLE 152 UK: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 201
TABLE 153 UK: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 201
TABLE 154 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 201

8.3.3 FRANCE 202
8.3.3.1 Statutory health insurance system to support market growth 202
TABLE 155 FRANCE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 202
TABLE 156 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 203
TABLE 157 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 203
TABLE 158 FRANCE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 203
TABLE 159 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 204
TABLE 160 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 204
TABLE 161 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 204
TABLE 162 FRANCE: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 205
TABLE 163 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 205
TABLE 164 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 205
8.3.4 ITALY 206
8.3.4.1 Rising incidence of lifestyle diseases such as obesity, hypertension, asthma, and diabetes to drive the adoption of patient monitoring devices 206
TABLE 165 ITALY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 206
TABLE 166 ITALY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 207
TABLE 167 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 207
TABLE 168 ITALY: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 207
TABLE 169 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 208
TABLE 170 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 208
TABLE 171 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 208
TABLE 172 ITALY: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 209
TABLE 173 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 209
TABLE 174 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 209
8.3.5 SPAIN 210
8.3.5.1 Growing number of surgical procedures to drive market growth in Spain 210
TABLE 175 SPAIN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 210
TABLE 176 SPAIN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 211
TABLE 177 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 211
TABLE 178 SPAIN: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 211
TABLE 179 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 212
TABLE 180 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 212
TABLE 181 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 212
TABLE 182 SPAIN: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 213
TABLE 183 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 213
TABLE 184 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 213
8.3.6 REST OF EUROPE (ROE) 214
TABLE 185 KEY MERGERS & ACQUISITIONS AND PARTNERSHIPS IN THE PATIENT MONITORING DEVICES MARKET IN THE ROE 214
TABLE 186 ROE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 215
TABLE 187 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 215
TABLE 188 ROE: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 216
TABLE 189 ROE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY,
2018–2025 (USD MILLION) 216
TABLE 190 ROE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 216
TABLE 191 ROE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 217
TABLE 192 ROE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 217
TABLE 193 ROE: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 217
TABLE 194 ROE: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 218
TABLE 195 ROE: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 218
8.4 ASIA PACIFIC 218
FIGURE 21 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET SNAPSHOT 219
TABLE 196 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 220
TABLE 197 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 220
TABLE 198 ASIA PACIFIC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 221
TABLE 199 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 221
TABLE 200 ASIA PACIFIC: MULTI-PARAMETER MONITORING DEVICES MARKET,
BY ACUITY, 2018–2025 (USD MILLION) 221
TABLE 201 ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 222
TABLE 202 ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 222
TABLE 203 ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 222
TABLE 204 ASIA PACIFIC: FETAL AND NEONATAL MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 223
TABLE 205 ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 223
TABLE 206 ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 223
TABLE 207 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY END USER, 2018–2025 (USD MILLION) 224
8.4.1 JAPAN 224
8.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth 224
TABLE 208 RECENT DEVELOPMENTS IN THE PATIENT MONITORING DEVICES MARKET IN JAPAN 225
TABLE 209 JAPAN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 226
TABLE 210 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 226
TABLE 211 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 227
TABLE 212 JAPAN: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 227
TABLE 213 JAPAN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 227
TABLE 214 JAPAN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 228
TABLE 215 JAPAN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 228
TABLE 216 JAPAN: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 228
TABLE 217 JAPAN: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 229
TABLE 218 JAPAN: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 229
8.4.2 CHINA 229
8.4.2.1 Growing focus of local and international market players on this market 229
TABLE 219 RECENT DEVELOPMENTS IN THE PATIENT MONITORING DEVICES MARKET IN CHINA 230
TABLE 220 CHINA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 231
TABLE 221 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 231
TABLE 222 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 232
TABLE 223 CHINA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 232
TABLE 224 CHINA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 232
TABLE 225 CHINA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 233
TABLE 226 CHINA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 233
TABLE 227 CHINA: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 233
TABLE 228 CHINA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 234
TABLE 229 CHINA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 234
8.4.3 INDIA 234
8.4.3.1 Increasing healthcare initiatives by government supporting growth of market 234
TABLE 230 INDIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 236
TABLE 231 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 236
TABLE 232 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 237
TABLE 233 INDIA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 237
TABLE 234 INDIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 237
TABLE 235 INDIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 238
TABLE 236 INDIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 238
TABLE 237 INDIA: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 238
TABLE 238 INDIA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 239
TABLE 239 INDIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 239
8.4.4 AUSTRALIA 239
8.4.4.1 Research and Development Tax Incentive Program to support market growth 239
TABLE 240 AUSTRALIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 240
TABLE 241 AUSTRALIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 240
TABLE 242 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 241
TABLE 243 AUSTRALIA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 241
TABLE 244 AUSTRALIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 241
TABLE 245 AUSTRALIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 242
TABLE 246 AUSTRALIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 242
TABLE 247 AUSTRALIA: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 242
TABLE 248 AUSTRALIA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 243
TABLE 249 AUSTRALIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 243
8.4.5 SOUTH KOREA 243
8.4.5.1 Supportive government initiatives expected to positively impact market growth 243
TABLE 250 SOUTH KOREA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 244
TABLE 251 SOUTH KOREA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 244
TABLE 252 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 245
TABLE 253 SOUTH KOREA: MULTI-PARAMETER MONITORING DEVICES MARKET,
BY ACUITY, 2018–2025 (USD MILLION) 245
TABLE 254 SOUTH KOREA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 245
TABLE 255 SOUTH KOREA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 246
TABLE 256 SOUTH KOREA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 246
TABLE 257 SOUTH KOREA: FETAL AND NEONATAL MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 246
TABLE 258 SOUTH KOREA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 247
TABLE 259 SOUTH KOREA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 247
8.4.6 REST OF ASIA PACIFIC 247
TABLE 260 RECENT DEVELOPMENTS IN THE PATIENT MONITORING DEVICES MARKET IN THE REST OF APAC 248
TABLE 261 ROAPAC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 249
TABLE 262 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION) 250
TABLE 263 ROAPAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 250
TABLE 264 ROAPAC: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 250
TABLE 265 ROAPAC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 251
TABLE 266 ROAPAC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 251
TABLE 267 ROAPAC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 251
TABLE 268 ROAPAC: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 252
TABLE 269 ROAPAC: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 252
TABLE 270 ROAPAC: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 252
8.5 LATIN AMERICA 253
TABLE 271 LATAM: PATIENT MONITORING DEVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 253
TABLE 272 LATAM: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 254
TABLE 273 LATAM: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 254
TABLE 274 LATAM: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 255
TABLE 275 LATAM: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 255
TABLE 276 LATAM: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 255
TABLE 277 LATAM: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 256
TABLE 278 LATAM: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 256
TABLE 279 LATAM: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 256
TABLE 280 LATAM: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 257
TABLE 281 LATAM: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 257
TABLE 282 LATAM: PATIENT MONITORING DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 257
8.5.1 BRAZIL 258
8.5.1.1 Brazil is a key market in Latin America owing to modernization of healthcare facilities 258
TABLE 283 BRAZIL: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 259
TABLE 284 BRAZIL: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 259
TABLE 285 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 260
TABLE 286 BRAZIL: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 260
TABLE 287 BRAZIL: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 260
TABLE 288 BRAZIL: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 261
TABLE 289 BRAZIL: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 261
TABLE 290 BRAZIL: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 261
TABLE 291 BRAZIL: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 262
TABLE 292 BRAZIL: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 262
8.5.2 MEXICO 262
8.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth 262
TABLE 293 MEXICO: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 263
TABLE 294 MEXICO: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 263
TABLE 295 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 264
TABLE 296 MEXICO: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 264
TABLE 297 MEXICO: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 264
TABLE 298 MEXICO: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 265
TABLE 299 MEXICO: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 265
TABLE 300 MEXICO: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 265
TABLE 301 MEXICO: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 266
TABLE 302 MEXICO: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 266
8.5.3 REST OF LATIN AMERICA 266
TABLE 303 ROLA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 267
TABLE 304 ROLA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 268
TABLE 305 ROLA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 268
TABLE 306 ROLA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY, 2018–2025 (USD MILLION) 268
TABLE 307 ROLA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 269
TABLE 308 ROLA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 269
TABLE 309 ROLA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 269
TABLE 310 ROLA: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 270
TABLE 311 ROLA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 270
TABLE 312 ROLA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 270
8.6 MIDDLE EAST & AFRICA 271
8.6.1 AWARENESS INITIATIVES TO DRIVE THE ADOPTION OF PATIENT MONITORING DEVICES IN THE REGION 271
TABLE 313 MEA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 272
TABLE 314 MEA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE,
2018–2025 (USD MILLION) 272
TABLE 315 MEA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 273
TABLE 316 MEA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY ACUITY,
2018–2025 (USD MILLION) 273
TABLE 317 MEA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 273
TABLE 318 MEA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 274
TABLE 319 MEA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 274
TABLE 320 MEA: FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 274
TABLE 321 MEA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 275
TABLE 322 MEA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 275
TABLE 323 MEA: PATIENT MONITORING DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 275
9 COMPETITIVE LANDSCAPE 276
9.1 MARKET OVERVIEW 276
FIGURE 22 COMPANIES ADOPTED PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS AS THEIR KEY GROWTH STRATEGY OVER
THE LAST TWO YEARS 276
9.2 MARKET SHARE ANALYSIS 277
9.2.1 HEMODYNAMIC MONITORING SYSTEMS MARKET 277
FIGURE 23 HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE,
BY KEY PLAYER, 2019 277
9.2.2 NEUROMONITORING DEVICES MARKET 278
FIGURE 24 NEUROMONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2019 278
9.2.3 CARDIAC MONITORING DEVICES MARKET RANKING ANALYSIS, 2019 279
TABLE 324 RANK OF COMPANIES IN THE GLOBAL CARDIAC MONITORING DEVICES MARKET, 2019 279
9.2.4 RESPIRATORY MONITORING DEVICES MARKET 280
FIGURE 25 PULSE OXIMETERS AND CAPNOGRAPH DEVICES MARKET SHARE,
BY KEY PLAYER, 2019 280
9.3 COMPETITIVE EVALUATION MATRIX AND METHODOLOGY 281
9.3.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS 281
9.3.1.1 Stars 281
9.3.1.2 Emerging leaders 281
9.3.1.3 Pervasive players 282
9.3.1.4 Participants 282
FIGURE 26 PATIENT MONITORING DEVICES MARKET COMPETITIVE LEADERSHIP MAPPING, 2019 282
9.4 COMPETITIVE SCENARIO 283
9.4.1 PRODUCT LAUNCHES & APPROVALS 283
TABLE 325 PRODUCT LAUNCHES & APPROVALS, 2019–2020 283
9.4.2 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 286
TABLE 326 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS,
2019–2020 286
9.4.3 MERGERS & ACQUISITIONS 288
TABLE 327 MERGERS & ACQUISITIONS, 2017–2020 288
9.4.4 EXPANSIONS 289
TABLE 328 EXPANSIONS, 2017–2020 289
10 COMPANY PROFILES 290
(Business overview, Products offered, Recent developments, Competition Analysis, MNM view)*
10.1 GE HEALTHCARE 290
FIGURE 27 GE HEALTHCARE: COMPANY SNAPSHOT (2019) 290
10.2 MEDTRONIC PLC 292
FIGURE 28 MEDTRONIC PLC: COMPANY SNAPSHOT (2019) 292
10.3 KONINKLIJKE PHILIPS N.V. 297
FIGURE 29 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019) 297
10.4 ABBOTT LABORATORIES 303
FIGURE 30 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 303
10.5 NIHON KOHDEN CORPORATION 306
FIGURE 31 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2019) 306
10.6 MASIMO CORPORATION 311
FIGURE 32 MASIMO CORPORATION: COMPANY SNAPSHOT (2019) 311
10.7 OMRON CORPORATION 318
FIGURE 33 OMRON CORPORATION: COMPANY SNAPSHOT (2019) 318
10.8 EDWARDS LIFESCIENCES CORPORATION 322
FIGURE 34 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2019) 322
10.9 HILL-ROM HOLDINGS, INC. 325
FIGURE 35 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2019) 325
10.10 DRÄGERWERK AG & CO. KGAA 329
FIGURE 36 DRÄGERWERK: COMPANY SNAPSHOT (2019) 329
10.11 NATUS MEDICAL 331
FIGURE 37 NATUS MEDICAL: COMPANY SNAPSHOT (2019) 331
10.12 GETINGE AB 334
FIGURE 38 GETINGE AB: COMPANY SNAPSHOT (2019) 334
10.13 COMPUMEDICS LIMITED 336
FIGURE 39 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2019) 336
10.14 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS 339
10.15 NONIN 341
*Business overview, Products offered, Recent developments, Competition Analysis, MNM view might not be captured in case of unlisted companies.
10.16 OTHER COMPANIES 343
10.16.1 BIOTRONIK 343
10.16.2 BOSTON SCIENTIFIC CORPORATION 343
10.16.3 BIOTELEMETRY 344
10.16.4 SCHILLER 344
10.16.5 DEXCOM, INC. 346
11 APPENDIX 347
11.1 DISCUSSION GUIDE: PATIENT MONITORING DEVICES MARKET 347
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 351
11.3 AVAILABLE CUSTOMIZATIONS 353
11.4 RELATED REPORTS 353
11.5 AUTHOR DETAILS 354

★調査レポート[患者モニタリング装置の世界市場予測(~2025):製品別、エンドユーザー別] ( Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitoring, MCOT, ECG, ICP, ILRs, Blood Glucose Monitoring, Blood Pressure Monitor), End-User (Hospitals, ASCs) - Global Forecast to 2025 / MD 2436) 販売に関する免責事項
[患者モニタリング装置の世界市場予測(~2025):製品別、エンドユーザー別] ( Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitoring, MCOT, ECG, ICP, ILRs, Blood Glucose Monitoring, Blood Pressure Monitor), End-User (Hospitals, ASCs) - Global Forecast to 2025 / MD 2436) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆